Trials / Conditions / Methamphetamine Use Disorder

Methamphetamine Use Disorder

38 registered clinical trials studyying Methamphetamine Use Disorder — 17 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study NCT07509112	Kirby Institute	Phase 2
Not Yet Recruiting	LDART for Stimulant Use Disorder NCT07221396	Yale University	N/A
Recruiting	Non-Abstinence Outcomes in Methamphetamine Use Disorder NCT07226596	William Stoops	N/A
Not Yet Recruiting	Why Wait? Initiating Contingency Management in Traumatically Injured Patients During Hospitalization NCT06931197	Queen's Medical Center	N/A
Not Yet Recruiting	Methamphetamine Use Disorder Support in Heart Failure Pilot Study NCT07211724	University of Southern California	N/A
Not Yet Recruiting	CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM NCT07213258	University of California, San Diego	N/A
Completed	Theta Burst Stimulation in the Management of Methamphetamine Use Disorder in Indonesia NCT07399431	Indonesia University	N/A
Recruiting	LRFN5 and OLFM4 in Methamphetamine-Induced Psychosis NCT07450027	Elazığ Mental Health and Diseases Hospital	—
Recruiting	Methamphetamine and Troriluzole NCT06989853	William Stoops	EARLY_Phase 1
Recruiting	Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder NCT06788587	Centre hospitalier de l'Université de Montréal (CHUM)	Phase 2
Completed	α-N-acetylgalactosaminidase in Methamphetamine Psychosis NCT07434401	Elazığ Mental Health and Diseases Hospital	—
Recruiting	ECG Findings in Methamphetamine Use NCT07459244	Elazığ Mental Health and Diseases Hospital	—
Recruiting	Psilocybin for Methamphetamine Addiction NCT06899594	Kevin Murnane	EARLY_Phase 1
Recruiting	A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disor NCT06712446	The University of Texas Health Science Center, Houston	N/A
Recruiting	Deep TMS of Neural Circuits Associated With Stimulant Use Disorder NCT06578429	Stanford University	N/A
Active Not Recruiting	Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV NCT06538285	Nicky Mehtani, MD, MPH	Phase 2
Active Not Recruiting	Screen, Treat and Retain People With Primary Meth Use Disorder at MMT Clinics NCT07121296	Hanoi Medical University	N/A
Active Not Recruiting	Tirzepatide for Obesity and Meth Use Disorder NCT06745128	University of Texas Southwestern Medical Center	Phase 2
Recruiting	Paired-pulse rTMS Treatment for Methamphetamine Use Disorder Based on the mPFC-Cerebellum NCT06457230	Shanghai Mental Health Center	N/A
Recruiting	Implementing a Contingency Management Program Addressing Methamphetamine Use For and With the People of Hawaii NCT06532370	Queen's Medical Center	N/A
Recruiting	Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder NCT06320366	University of Colorado, Denver	N/A
Recruiting	Methamphetamine Cue-reactivity NCT07086014	Icahn School of Medicine at Mount Sinai	—
Active Not Recruiting	Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder NCT05558358	University of Colorado, Denver	Phase 1 / Phase 2
Completed	Beginning Early and Assertive Treatment for Methamphetamine Use Disorder NCT06033365	Denver Health and Hospital Authority	N/A
Completed	Intranasal Oxytocin for Methamphetamine Withdrawal in Women NCT05760807	Turning Point	N/A
Terminated	The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder NCT05711862	The University of Texas Health Science Center, Houston	Phase 2
Active Not Recruiting	Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder NCT05322954	University of Wisconsin, Madison	Phase 1
Unknown	A Study for the Risky Decision-making Deficits Among Methamphetamine Dependence Individuals and Treatment NCT06279273	Shanghai Mental Health Center	N/A
Completed	rTMS for Stimulant Use Disorders NCT04907357	Medical University of South Carolina	N/A
Completed	Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM NCT04791969	Glenn-Milo Santos	Phase 2
Active Not Recruiting	TACS Intervention for Methamphetamine Addiction NCT06288997	Shanghai Mental Health Center	N/A
Completed	Mirtazapine and Methamphetamine Drug-drug Interaction Study NCT04614584	San Francisco Department of Public Health	Phase 1
Completed	A Telephone-delievered Intervention to Reduce Methamphetamine Use NCT04713124	Turning Point	N/A
Completed	Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine] NCT04178993	Craig Rush	Phase 1
Terminated	Study of Pomaglumetad and Methamphetamine NCT03106571	University of California, Los Angeles	Phase 1
Completed	Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder NCT03078075	University of Texas Southwestern Medical Center	Phase 3
Completed	Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder NCT01982643	Walter Ling	Phase 1 / Phase 2
Completed	Bupropion in the Treatment of Methamphetamine Dependence NCT00572234	University of Nebraska	N/A